| Betty Zondervan, RN | |
|
14255 Sw Brigadoon Ct, Beaverton, OR 97005-3369 | |
| (503) 641-1475 | |
| (503) 641-8548 |
| Full Name | Betty Zondervan |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Psychiatric/mental Health |
| Location | 14255 Sw Brigadoon Ct, Beaverton, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003945544 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WP0808X | Registered Nurse - Psychiatric/mental Health | 98006796 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Betty Zondervan, RN 14600 Nw Cornell Rd, Portland, OR 97229-5442 Ph: (503) 645-3581 | Betty Zondervan, RN 14255 Sw Brigadoon Ct, Beaverton, OR 97005-3369 Ph: (503) 641-1475 |
News Archive
As Africa marks its own Malaria Day in recognition of the fact that it bears 90% of the deadly disease's burden, an international research coalition is working to develop a cocktail of drugs that overcomes increasing resistance to conventional treatment exhibited by the elusive parasite.
The Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses - 2.5% and 3.75% - administered daily on a 2-week treatment cycle. The study demonstrates that both formulations were superior to placebo, and that imiquimod 3.75% on a daily 2-week treatment cycle is superior to imiquimod 2.5% in treating actinic keratosis (AK) on a large surface area - the face or balding scalp.
Heart and cerebro-vascular disorders represent the two leading causes of death throughout the world. They are sometimes combined in a single patient and their combination represents both a considerable risk to the patient and a therapeutic challenge.
The 1920s-era charge that national health insurance was socialist eventually begat Ronald Reagan's 1961 anti-Medicare record album. A 1972 carve-out won special Medicare treatment for patients with end-stage renal disease.
Medical & Biological Laboratories Co., Ltd. (MBL), with the collaboration of Osaka University, has successfully generated several fully human monoclonal antibodies against pandemic A (H1N1 and H3N2) type influenza virus by utilizing blood samples from volunteers who were inoculated with influenza vaccine.
› Verified 5 days ago
Mrs. Eva Torsiende Santos, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 740 Nw 180th Ave, Beaverton, OR 97006 Phone: 503-629-0763 | |
Judy Vickery, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 20545 Sw Parker Ct, Beaverton, OR 97078 Phone: 503-719-9515 | |
Julie Nittler, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 14255 Sw Brigadoon Ct, Beaverton, OR 97005 Phone: 503-641-1475 Fax: 503-641-8548 | |
Zuzana Kalas, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 14255 Sw Brigadoon Ct, Beaverton, OR 97005 Phone: 971-246-5240 | |
Dixie Hofer, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7380 Sw 163rd Pl, Beaverton, OR 97007 Phone: 503-848-7069 | |
Jennifer Helen Barnes, PMHNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 16100 Nw Cornell Rd # 220, Beaverton, OR 97006 Phone: 503-878-8885 |